| Literature DB >> 21364904 |
Nitin Udar1, Kent Small, Meenal Chalukya, Rosamaria Silva-Garcia, Michael Marmor.
Abstract
PURPOSE: Enhanced S Cone Syndrome is a rare autosomal recessive disorder characterized clinically by an absence of rod function, a replacement of most L and M cone function by S cone activity (Goldmann-Favre Syndrome) and by variable degrees of retinal degeneration in different families. The causative gene, nuclear receptor subfamily 2, group E, member 3 (NR2E3), controls the developmental sequence for rods and cones. The purpose of this study was to compare the nature and implications of mutations in two subjects with Enhanced S Cone Syndrome who have significantly different degrees of degenerative damage.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21364904 PMCID: PMC3044695
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Primer sequence
| NR2E3–1AF | AGCATGGGGTAGCAGGACTGAC |
| NR2E3–1AR | TTGGTCTGGTCTCCATGGGTTAC |
| NR2E3–1BF | GGCAGCTCCTGAGTTCAGACAGA |
| NR2E3–1BR | CTGAGTTGTTCTGGCTCCTTCCA |
| NR2E3–2F | GTTCGTTCAAATGCGGGTGAG |
| NR2E3–2R | GGTCAGTGTCCCTCCCATGC |
| NR2E3–3F | AGGGGTTCTGGAGGGGTGAG |
| NR2E3–3R | GGACTCAGTGTTGGACTCCATGC |
| NR2E3–4AF | CAGGCGGGGATGAACCAG |
| NR2E3–4AR | TTATAAGGCTGGCCATGAAGTGG |
| NR2E3–4BF | GCATGGAGTCCAACACTGAGTCC |
| NR2E3–4BR | TGTGATCTTAGCGCCTGCTTCTC |
| NR2E3–5AF | AGGATGGTGAGTGGGAGAGCAG |
| NR2E3–5AR | ATGAAGAGTAGGCGAGCCGAGGT |
| NR2E3–5BF | CCTGAGTTCCCCTCCTCTCCATA |
| NR2E3–5BR | ATCACCATCCAAGCTGTGTGCAT |
| NR2E3–6AF | CTGGCTGATGTCAGGAGAGCATT |
| NR2E3–6AR | CCGGAACCGAGAGATAGTTTCCT |
| NR2E3–6BF | GGCGTGGAGTGAACTCTTTCTCC |
| NR2E3–6BR | AGTCCAGCCTCACCACTCTCCTC |
| NR2E3–7AF | CAGAGCCCACCCCACAGG |
| NR2E3–7AR | TGAACTGAGACCCTTGTGCTGTC |
| NR2E3–7BF | CCCGTGAGGTGACCTGAGCAT |
| NR2E3–7BR | CAAAGTCCCTCCCAATTCTGCTT |
| NR2E3–7CF | CCCTAGCCAGGTACTGAGGGTTG |
| NR2E3–7CR | AGCCCTGTGTATGACCCTCTGCT |
| NR2E3–7DF | AGCCCGTTCAGGACTTTGAATG |
| NR2E3–7DR | TCCATGTGCTTGGCATCTCTACA |
| NR2E3–8AF | ATGTGGCTTTTCCTCGAAATTCCT |
| NR2E3–8AR | CCATCAATATACAGTTTGGGGCTAT |
| NR2E3–8BF | GCAATTCCTCGTAGGTGTGTGTACC |
| NR2E3–8BR | TGCCCAGATCAAAATCAACATTTCT |
| NR2E3–8CF | TATGCAGAGTTCAGGAACAGGCAAG |
| NR2E3–8CR | GGGTGGTTGAATTCTATGGGAGATT |
Figure 1Electroretinograms comparing normal tracings to Case 1 and Case 2. Case 1 shows electroretinogram (ERG) amplitudes similar to the normal dark-adapted combined rod-cone response under both scotopic and photopic conditions (Scale bars show amplitude 500 microvolts, duration 75 ms). The responses from Case 2 have similar waveform, and scotopic-photopic homology, but lower amplitude.
Figure 2DNA sequencing of the NR2E3 gene in family 1 with the propositus #2743 showing the homozygous deletion. Pedigree: + - indicate individual that have been examined. Black solid fill ● – affected phenotype. White solid fill □ – normal phenotype. Pattern filled square and circle– individual assumed carrier. # - Sample Number.
Figure 3Sequence of intron 1 and exon 2 of NR2E3 showing the mutations of Case 1 and 2. Repeat sequences are given in bold. The novel mutations of Case 1 are underlined. The mutations of Case 2 are shaded. A square box defines the P-box.
Figure 4DNA sequencing of the NR2E3 gene in family 2. Individual #2883 illustrates the compound heterozygous mutation. Pedigree: + - indicate individual that have been examined. Black solid fill ● – affected phenotype. White solid fill □ – normal phenotype. Pattern filled square and circle– individual assumed carrier. # - Sample Number.